High-Potency Cannabis: America’s New Pastime and Psychiatry’s Next Challenge
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthTHCSafetyPolicyResearch Why This Matters Clinicians need to understand that high-potency cannabis…
CBD THC Gummies for Weight Loss: What the Evidence Shows and How They Fit Into a …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Weight ManagementCbdThcMetabolismAppetite…
CBD Gummies to Lower Blood Sugar: What the Evidence Actually Shows
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DiabetesCbdGlucose ControlDrug…
Behavioral Science in Clinical Trials: Part 3 — Why Diversity Must Be Built Into Trial Design
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Clinical TrialsHealth EquityResearch…
Safety of cannabidiol versus placebo in healthy population: a systematic review and meta-analysis.
Cannabidiol (CBD) has gained significant attention for its potential therapeutic benefits, but its safety profile in healthy populations remains underexplore...
Cannabis industry launches organization to further US policy changes with members from …
WHY IT MATTERS: The policies shaped by this kind of industry coalition could directly affect what medical cannabis products are available to patients, how they are labeled, and whether insurance or federal programs ever cover them. CLINICAL OVERVIEW: The…
Cannabis research: India to start human trials for medicinal marijuana – NewsBytes
WHY IT MATTERS: If India's human trials produce strong safety and efficacy data, it could accelerate regulatory acceptance of medicinal cannabis across South and Southeast Asia, potentially expanding patient access in regions where options are currently…
Op-Ed: Cannabis Policy Needs Pharmacists | Pharmacy Times
WHY IT MATTERS: If pharmacists become part of the cannabis care team, patients would benefit from professional drug interaction checks, standardized dosing advice, and a layer of safety oversight that most dispensaries currently cannot provide. CLINICAL…
5 Exciting Insights from the MedCan 3 Trial
MedCan 3: A Landmark Study on Medicinal Cannabis for Cancer Symptom Management Read The Study Publication The MedCan 3 study is a highly anticipated clinical trial investigating the potential of medicinal cannabis to alleviate symptoms in…